drugset / Trial / NCT00156858

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

NCT00156858

Unknown 200 enrolled Alberta Health services
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study of pharmacokinetics of daily intravenous busulfan

Timeline

Start
1998-01
Primary completion
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule Intravenous